focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBluefield Solar Regulatory News (BSIF)

Share Price Information for Bluefield Solar (BSIF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 106.60
Bid: 106.60
Ask: 107.00
Change: -1.40 (-1.30%)
Spread: 0.40 (0.375%)
Open: 107.20
High: 108.00
Low: 106.60
Prev. Close: 108.00
BSIF Live PriceLast checked at -
Bluefield Solar Income Fund is an Investment Trust

To provide Shareholders with an attractive return, principally in the form of quarterly income distributions by being invested primarily in solar energy assets located in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

3 Dec 2021 12:00

RNS Number : 5454U
Bluefield Solar Income Fund Limited
03 December 2021
 

3 December 2021

 

Bluefield Solar Income Fund Limited

('Bluefield Solar' or the 'Company')

 

Result of Annual General Meeting

 

Bluefield Solar (LON: BSIF), a UK income fund focused on acquiring and managing UK-based renewable energy and storage projects to provide growing dividends for its shareholders whilst furthering the decarbonisation of the energy system, announces that at the Annual General Meeting ("AGM") of the Company held at 11.00 am, 3 December 2021, Ordinary Resolutions 1 to 13 and Special Resolutions 14 and 15 were passed without amendment.

 

The full text of the Special Resolutions is noted below:

 

Resolution 14

 

That, in substitution for any existing disapplication authority in force as at the date of this Annual General Meeting, the Directors be and are hereby generally and unconditionally authorised to allot, issue and/or sell equity securities for cash as if article 6.2 of the Articles of Incorporation did not apply to any such allotment, issue and/or sale, provided that this power shall be limited to the allotment, issue and/or sale of up to 10 per cent. of the Ordinary Shares in issue as at the date of this Annual General Meeting for the period expiring at the date falling 15 months after the date of the passing of this resolution or the conclusion of the next annual general meeting of the Company, whichever is earlier (unless previously renewed, varied or revoked by the Company in a general meeting), save that the Company shall be entitled to make offers or agreements before the expiry of such power which would or might require equity securities to be allotted and issued after such expiry and the Directors shall be entitled to allot and issue equity securities pursuant to any such offer or agreement as if the power conferred hereby had not expired.

 

Resolution 15

 

That, in addition to any existing authorities granted to the Directors, the Directors be, and hereby are, empowered to allot, issue and/or sell equity securities for cash as if article 6.2 of the Articles of Incorporation did not apply to any such allotment, issue and/or sale, provided that this power shall be limited to the allotment, issue and/or sale of up to an additional 10 per cent. of the Ordinary Shares in issue as at the date of this Annual General Meeting for the period expiring at the date falling 15 months after the date of the passing of this resolution or the conclusion of the next annual general meeting of the Company, whichever is earlier (unless previously renewed, varied or revoked by the Company in general meeting), save that the Company shall be entitled to make offers or agreements before the expiry of such power which would or might require equity securities to be allotted and issued after such expiry and the Directors shall be entitled to allot and issue equity securities pursuant to any such offer or agreement as if the power conferred hereby had not expired.

 

The voting breakdown of all resolutions follow:

 

Resolution

Votes For**

Votes Against

Votes Withheld*

1 - Ordinary

334,843,292

99.91%

293,115

0.09%

81,950

2 - Ordinary

334,310,149

99.76%

792,272

0.24%

115,936

3 - Ordinary

325,479,186

99.77%

755,218

0.23%

8,983,953

4 - Ordinary

325,474,851

99.77%

764,537

0.23%

8,978,969

5 - Ordinary

326,022,302

97.29%

9,076,276

2.71%

119,779

6 - Ordinary

326,711,323

97.49%

8,401,157

2.51%

105,877

7 - Ordinary

325,906,576

99.90%

333,211

0.10%

8,978,570

8 - Ordinary

334,738,693

99.89%

377,800

0.11%

101,864

9 - Ordinary

325,305,852

97.07%

9,823,487

2.93%

89,018

10 - Ordinary

334,736,151

99.88%

389,365

0.12%

92,841

11 - Ordinary

334,835,985

99.91%

300,473

0.09%

81,899

12 - Ordinary

334,853,786

99.92%

284,850

0.08%

79,721

13 - Ordinary

334,736,938

99.90%

340,132

0.10%

141,287

14 - Special

334,435,671

99.80%

679,428

0.20%

103,258

15 - Special

324,118,767

96.72%

10,996,332

3.28%

103,258

 

*A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes "for" or "against" the Resolution.

** including discretionary votes.

 

 

For further information:

 

Bluefield Partners LLP (Company Investment Adviser)James Armstrong / Neil Wood / Giovanni Terranova

Tel: +44 (0) 20 7078 0020www.bluefieldllp.com

 

Numis Securities Limited (Company Broker)Tod Davis / David Benda

 

Tel: +44 (0) 20 7260 1000www.numis.com

 

Ocorian Administration (Guernsey) Limited (Company Secretary & Administrator)Patrick Ogier

 

Tel: +44 (0) 1481 742 742www.ocorian.com

 

Media enquiries: Buchanan (PR Adviser)Henry Harrison-Topham / Henry Wilson / Victoria Hayns

Tel: +44 (0) 20 7466 5000www.buchanan.uk.comBSIF@buchanan.uk.com

 

 

Notes to Editors

About Bluefield Solar

Bluefield Solar is a UK income fund focused, primarily, on acquiring and managing UK-based solar projects to generate renewable energy for periods of typically 25 years or longer. Not less than 75% of the Company's gross assets will be invested into UK solar assets. The Company can also invest up to 25% of its gross assets into wind, hydro and storage technologies. Its primary objective is to deliver to its shareholders stable, long term sterling income via quarterly dividends. The majority of the Group's revenue streams are regulated and non-correlated to the UK energy market. Bluefield Solar owns and operates one of the UK's largest, diversified portfolios of solar and wind assets with a combined installed power capacity in excess of 625 MWp.

 

Further information can be viewed at www.bluefieldsif.com

 

LEI Code 2138004ATNLYEQKY4B30

 

About Bluefield Partners LLP ('Bluefield')

Bluefield Partners was established in 2009 and is an investment adviser to companies and funds investing in renewable energy infrastructure. It has a proven record in the selection, acquisition, and supervision of large-scale energy assets in the UK and Europe. The team has been involved in over £4 billion renewable funds and/or transactions in both the UK and Europe since 2008, including over £1 billion in the UK since December 2011.

 

Bluefield Partners has led the acquisitions of, and currently advises on, over 200 solar PV and wind assets in the UK and Europe that are agriculturally, commercially, or industrially situated. Based in its London office, it is supported by a dedicated and highly experienced team of investment, legal and portfolio executives. Bluefield Partners was appointed Investment Adviser to Bluefield Solar in June 2013.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFSMFFDEFSELE
Date   Source Headline
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20243:57 pmRNSDirector/PDMR Shareholding
15th Mar 20241:52 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20243:02 pmRNSDirector/PDMR Shareholding
28th Feb 20243:07 pmRNSDirector/PDMR Shareholding
28th Feb 20247:00 amRNSInterim Results to 31 December 2023
15th Feb 20247:00 amRNSNAV Update and £20m Share Buyback Programme
26th Jan 20247:00 amRNSFirst Interim Dividend
25th Jan 20247:00 amRNSCompletion of Phase One of Strategic Partnership
23rd Jan 20244:39 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSNotice of Interim Results
22nd Dec 20237:00 amRNSStrategic Partnership with GLIL Infrastructure
1st Dec 20237:00 amRNSChange to Director Roles and Responsibilities
28th Nov 20233:55 pmRNSResult of AGM
27th Nov 20238:00 amRNSHolding(s) in Company
20th Nov 20237:01 amRNSChange to Director Roles and Responsibilities
20th Nov 20237:00 amRNSDirector Appointment
16th Nov 20235:59 pmRNSCorrection - Unaudited NAV as at 30 September 2023
16th Nov 20237:00 amRNSUnaudited NAV as at 30 September 2023
27th Oct 20237:00 amRNSNotice of AGM
23rd Oct 20239:47 amRNSHolding(s) in Company
5th Oct 20237:00 amRNSAnalyst and Investor Site Visit
4th Oct 20234:31 pmRNSUpdate from QuotedData
2nd Oct 20234:47 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSDirector Retirement and New Audit Chair
28th Sep 20237:01 amRNSFourth Interim Dividend
28th Sep 20237:00 amRNSAnnual Report for the Year Ended 30 June 2023
13th Sep 20232:40 pmRNSHolding(s) in Company
5th Sep 20233:27 pmRNSHolding(s) in Company
24th Aug 202312:47 pmRNSDirector/PDMR Shareholding
23rd Aug 20235:03 pmRNSDirector/PDMR Shareholding
18th Aug 202312:10 pmRNSDirector/PDMR Shareholding
18th Aug 202312:08 pmRNSDirector/PDMR Shareholding
17th Aug 20233:58 pmRNSDirector/PDMR Shareholding
17th Aug 20237:00 amRNSUnaudited Net Asset Value as of 30 June 2023
7th Aug 202312:12 pmRNSThird Interim Dividend Announcement - Replacement
7th Aug 20237:00 amRNSThird Interim Dividend Announcement
22nd Jun 20237:00 amRNSRCF Increase and Extension
7th Jun 20237:00 amRNSConclusion of Audit Tender Process
18th May 20235:21 pmRNSChange to Director Roles and Responsibilities
11th May 20237:00 amRNSUnaudited NAV 31 Mar 2023 and 2nd Interim Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.